WALTHAM, MA, The Mito Fund, has invested in Pretzel Therapeutics, a Massachusetts-based company focused on harnessing cellular energetics.
The United Mitochondrial Disease Foundation's (UMDF) venture philanthropy arm, The Mito Fund, has invested in Pretzel Therapeutics, a Massachusetts-based company with research facilities in Molndal, Sweden, focused on harnessing cellular energetics to modulate disease processes and improve survival, function and quality of life for a breadth of conditions.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
